ACE and hypercalcemia disease: The suggested effect of bisphosphonates is the reduction of plasma calcium without reduction of 1,25-(OH)2-D or ACE, showing that hypercalcemia is secondary to the effect of 1,25-(OH)2-D on bone and that bisphosphonates do not directly affect granuloma activity [15].